Insider sale
RETINALGENIX TECHNOLOGIES INC.
$583.7K
182.40K shares
What this filing means
BAYERN STEVEN plans to sell 182.40K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $583.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/25/2026ACC: 0001493152-26-007996
182.40K
Shares to sell
$583.7K
Approx. market value
4.21M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
EXERCISE WARRANT
CHECK
9/1/2018
4.21MTotal acquired4.21M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2018 | EXERCISE WARRANT CHECK | 4.21M | — |
| Total | 4.21M | ||
Planned & Completed Dispositions1
OTCQBPlanned
Units to sell
182.40K
Market value
$583.7K
2/26/2026
Total
Units
182.40K
Value
$583.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/26/2026 | 182.40K | $583.7K | OTCQB | Planned |
| Total | 182.40K | $583.7K | ||